2023 Q2 Form 10-Q Financial Statement

#000140549523000020 Filed on May 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $101.6M $202.4M $101.3M
YoY Change -18.5% 99.74% 23.01%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $28.34M $33.68M $10.88M
YoY Change 197.78% 209.47% -2.97%
% of Gross Profit
Research & Development $49.88M $49.43M $17.61M
YoY Change 191.92% 180.66% -22.01%
% of Gross Profit
Depreciation & Amortization $19.65M $19.53M $19.28M
YoY Change -7.13% 1.27% -2.92%
% of Gross Profit
Operating Expenses $78.22M $83.11M $28.50M
YoY Change 194.02% 191.66% -15.69%
Operating Profit $23.38M $119.3M $30.19M
YoY Change -53.15% 295.1% 151.77%
Interest Expense $12.14M $12.09M $5.515M
YoY Change 93.57% 119.17% -21.1%
% of Operating Profit 51.94% 10.13% 18.27%
Other Income/Expense, Net $14.39M $13.19M -$1.214M
YoY Change -195.81% -1186.57% -809.94%
Pretax Income $25.62M $120.4M $23.67M
YoY Change -10.45% 408.62% 313.51%
Income Tax $4.329M $16.85M $5.961M
% Of Pretax Income 16.9% 13.99% 25.19%
Net Earnings $21.78M $105.3M $17.99M
YoY Change 3.39% 484.97% 222.99%
Net Earnings / Revenue 21.44% 52.01% 17.76%
Basic Earnings Per Share $0.81 $3.66 $0.59
Diluted Earnings Per Share $0.79 $3.58 $0.58
COMMON SHARES
Basic Shares Outstanding 26.74M shares 29.67M shares 30.70M shares
Diluted Shares Outstanding 27.66M shares 29.37M shares 31.28M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $840.7M $950.7M $899.2M
YoY Change -6.65% 5.72% 1.64%
Cash & Equivalents $277.6M $430.6M $783.0M
Short-Term Investments $563.1M $520.1M $116.2M
Other Short-Term Assets $11.17M $7.806M $4.687M
YoY Change 338.56% 66.55% 42.46%
Inventory
Prepaid Expenses $10.39M $13.45M $8.662M
Receivables $236.8M $144.0M $23.64M
Other Receivables $79.80M $66.85M $55.29M
Total Short-Term Assets $1.192B $1.196B $1.001B
YoY Change 15.09% 19.5% 1.66%
LONG-TERM ASSETS
Property, Plant & Equipment $11.68M $11.45M $12.32M
YoY Change 3.75% -7.06% -21.19%
Goodwill $22.42M $22.42M $22.42M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $19.58M $19.72M $21.28M
YoY Change -13.69% -7.35%
Other Assets $125.1M $114.7M $104.2M
YoY Change 30.71% 10.11% 45.92%
Total Long-Term Assets $568.0M $552.1M $594.8M
YoY Change -2.35% -7.17% 3.09%
TOTAL ASSETS
Total Short-Term Assets $1.192B $1.196B $1.001B
Total Long-Term Assets $568.0M $552.1M $594.8M
Total Assets $1.760B $1.749B $1.596B
YoY Change 8.82% 9.56% 2.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.313M $8.464M $6.013M
YoY Change -9.86% 40.76% -30.02%
Accrued Expenses $108.3M $57.66M $53.17M
YoY Change 141.32% 8.45% 28.26%
Deferred Revenue $172.7M $178.8M $238.6M
YoY Change 2.49% -25.06% 24.01%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $125.6M
YoY Change
Total Short-Term Liabilities $446.5M $254.4M $308.6M
YoY Change 91.67% -17.57% 21.87%
LONG-TERM LIABILITIES
Long-Term Debt $483.9M $607.9M $424.1M
YoY Change -19.91% 43.34% 1.12%
Other Long-Term Liabilities $56.82M $55.89M $50.78M
YoY Change 13.69% 10.07% 14.07%
Total Long-Term Liabilities $540.7M $663.8M $474.9M
YoY Change -17.35% 39.78% 2.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $446.5M $254.4M $308.6M
Total Long-Term Liabilities $540.7M $663.8M $474.9M
Total Liabilities $1.160B $1.123B $835.4M
YoY Change 24.41% 34.46% 0.73%
SHAREHOLDERS EQUITY
Retained Earnings $1.396B $1.384B $1.448B
YoY Change -4.27% -4.41% 6.61%
Common Stock $693.0K $693.0K $718.0K
YoY Change -3.62% -3.48% 0.56%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.484B $1.410B
YoY Change 5.28% 1.75%
Treasury Stock Shares
Shareholders Equity $595.2M $619.7M $753.7M
YoY Change
Total Liabilities & Shareholders Equity $1.760B $1.749B $1.596B
YoY Change 8.82% 9.56% 2.19%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $21.78M $105.3M $17.99M
YoY Change 3.39% 484.97% 222.99%
Depreciation, Depletion And Amortization $19.65M $19.53M $19.28M
YoY Change -7.13% 1.27% -2.92%
Cash From Operating Activities -$45.44M -$27.85M -$17.97M
YoY Change 34.57% 54.97% 82.61%
INVESTING ACTIVITIES
Capital Expenditures $13.04M $1.209M $337.0K
YoY Change -209.77% 258.75% -12.92%
Acquisitions
YoY Change
Other Investing Activities -$40.05M -$5.982M $117.8M
YoY Change -185.22% -105.08% -418.09%
Cash From Investing Activities -$53.08M -$14.46M $107.6M
YoY Change -251.17% -113.44% -328.81%
FINANCING ACTIVITIES
Cash Dividend Paid $10.38M $10.74M
YoY Change -3.32% -0.42%
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net $0.00
YoY Change
Cash From Financing Activities -53.32M -$218.1M -$13.04M
YoY Change -198.67% 1572.69% -34.37%
NET CHANGE
Cash From Operating Activities -45.44M -$27.85M -$17.97M
Cash From Investing Activities -53.08M -$14.46M $107.6M
Cash From Financing Activities -53.32M -$218.1M -$13.04M
Net Change In Cash -151.8M -$260.5M $76.59M
YoY Change -374.18% -440.06% -199.81%
FREE CASH FLOW
Cash From Operating Activities -$45.44M -$27.85M -$17.97M
Capital Expenditures $13.04M $1.209M $337.0K
Free Cash Flow -$58.48M -$29.06M -$18.31M
YoY Change 167.11% 58.73% 78.99%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001405495
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3M
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-33579
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
INTERDIGITAL, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
PA
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-4936666
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
200 Bellevue Parkway
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Wilmington
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
DE
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19809-3727
CY2023Q1 dei City Area Code
CityAreaCode
302
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
281-3600
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
IDCC
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
26741717 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
430625000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
693479000 usd
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
520059000 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
508298000 usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
144038000 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
53182000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
101692000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
89716000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
1196414000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1344675000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11445000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11338000 usd
CY2023Q1 idcc Finite Lived Patents Net
FiniteLivedPatentsNet
344205000 usd
CY2022Q4 idcc Finite Lived Patents Net
FiniteLivedPatentsNet
353999000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
81748000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
94373000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
114746000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
95720000 usd
CY2023Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
552144000 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
555430000 usd
CY2023Q1 us-gaap Assets
Assets
1748558000 usd
CY2022Q4 us-gaap Assets
Assets
1900105000 usd
CY2023Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
8464000 usd
CY2022Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
9997000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
18565000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
38400000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
178816000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
189059000 usd
CY2023Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
9449000 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
10384000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
39099000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
23506000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
254393000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
271346000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
607914000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
607066000 usd
CY2023Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
205057000 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
237580000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
55893000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
53600000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1123257000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1169592000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
14399000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
14399000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
69329000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71923000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27074000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29668000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
693000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
719000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
719129000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
717102000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1384243000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1492046000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-337000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-916000 usd
CY2023Q1 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
2103728000 usd
CY2022Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
2208951000 usd
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
42255000 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
42255000 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
1484056000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1484056000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
619672000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
724895000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
5629000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
5618000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
625301000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
730513000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1748558000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1900105000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
202373000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
101318000 usd
CY2023Q1 idcc Research And Portfolio Development Expense
ResearchAndPortfolioDevelopmentExpense
49429000 usd
CY2022Q1 idcc Research And Portfolio Development Expense
ResearchAndPortfolioDevelopmentExpense
44177000 usd
CY2023Q1 idcc Licensing Costs
LicensingCosts
21368000 usd
CY2022Q1 idcc Licensing Costs
LicensingCosts
15530000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12315000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10884000 usd
CY2023Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
0 usd
CY2022Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
542000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
83112000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
71133000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
119261000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
30185000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
12087000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
5515000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13191000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1005000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
120365000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23665000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16845000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5961000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
103520000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
17704000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1739000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-290000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
105259000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
17994000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.66
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28780000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30703000 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.58
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29372000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31275000 shares
CY2023Q1 us-gaap Profit Loss
ProfitLoss
103520000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
17704000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
579000 usd
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-310000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
104099000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
17394000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1739000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-290000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
105838000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
17684000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
752917000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
17994000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-290000 usd
CY2022Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1928000 usd
CY2022Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
1500000 usd
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-310000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.35
CY2022Q1 us-gaap Dividends
Dividends
10803000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1226000 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-5026000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5386000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
760666000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
730513000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
105259000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1739000 usd
CY2023Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
1750000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
579000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.35
CY2023Q1 us-gaap Dividends
Dividends
9449000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
687000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-6708000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7790000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
203381000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
625301000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
103520000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
17704000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19526000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19282000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-3434000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1498000 usd
CY2023Q1 idcc Non Cash Changein Fair Value
NonCashChangeinFairValue
-158000 usd
CY2022Q1 idcc Non Cash Changein Fair Value
NonCashChangeinFairValue
0 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-42766000 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-50741000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-12471000 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-2492000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7790000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5386000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
2500000 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
67000 usd
CY2022Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
0 usd
CY2023Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
90856000 usd
CY2022Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-7475000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
31091000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2772000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2807000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
420000 usd
CY2023Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-2614000 usd
CY2022Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-18716000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27852000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17972000 usd
CY2023Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
309393000 usd
CY2022Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
2139000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
303411000 usd
CY2022Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
119950000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1209000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
337000 usd
CY2023Q1 idcc Capitalized Patent Costs
CapitalizedPatentCosts
7272000 usd
CY2022Q1 idcc Capitalized Patent Costs
CapitalizedPatentCosts
9872000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14463000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
107602000 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
100000 usd
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
203381000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
687000 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1226000 usd
CY2023Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
1750000 usd
CY2022Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
1500000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6708000 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5026000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
10384000 usd
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
10741000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-218136000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13041000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-260451000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
76589000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
703161000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
713224000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
442710000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
789813000 usd
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
CY2023Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to prior year amounts to conform to the current year presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, the Company made reclassifications between the operating expenses lines on the consolidated income statement in order to more clearly reflect the Company’s investments to create and protect the value of our innovations. The Company grouped research and portfolio related costs within the line "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and portfolio development</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">", previously referred to as "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Development</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">", which resulted in reclassifying certain portfolio related costs out of the "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Licensing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" line, previously referred to as "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patent administration and licensing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">", and into "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and portfolio development.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" The impact of this reclassification was $26.6 million for the three months ended March 31, 2022. Additionally, the previous "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general, and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" line is now referred to as "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">".</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in third quarter 2022, we updated our disaggregated revenue disclosures to provide information to enable investors to better understand the composition of revenue from contracts with customers. As a result, variable patent royalty revenue and fixed-fee royalty revenue was combined and disaggregated into the Smartphone and CE, IoT/Auto groupings. Additionally, the Other category includes current technology solutions revenues and catch-up revenues is comprised of past patent royalties and revenues from static agreements. We believe this better reflects both our current revenue sources and our growth opportunities across these vertical markets.</span></div>
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
4942000 usd
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
3349000 usd
CY2023Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
9449000 usd
CY2022Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
10803000 usd
CY2023Q1 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
0 usd
CY2022Q1 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
30100000 usd
CY2023Q1 idcc Noncash Distribution Of Patents
NoncashDistributionOfPatents
0 usd
CY2022Q1 idcc Noncash Distribution Of Patents
NoncashDistributionOfPatents
1928000 usd
CY2023Q1 idcc Increase Decrease In Capital And Intangible Asset Expenditures Incurred But Not Yet Paid
IncreaseDecreaseInCapitalAndIntangibleAssetExpendituresIncurredButNotYetPaid
-1274000 usd
CY2022Q1 idcc Increase Decrease In Capital And Intangible Asset Expenditures Incurred But Not Yet Paid
IncreaseDecreaseInCapitalAndIntangibleAssetExpendituresIncurredButNotYetPaid
1562000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
202373000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
101318000 usd
CY2023Q1 idcc Increase Decrease In Disaggregated Revenue
IncreaseDecreaseInDisaggregatedRevenue
101055000 usd
CY2023Q1 idcc Percentage Increase Decrease In Disaggregated Revenue
PercentageIncreaseDecreaseInDisaggregatedRevenue
1
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
59100000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
133100000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
19600000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
32900000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
2500000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
267055000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
295464000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
282709000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
215487000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
213257000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
472696000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1746668000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.140
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.252
CY2023Q1 idcc Effective Income Tax Rate Reconciliation Excluding Valuation Allowance Percent
EffectiveIncomeTaxRateReconciliationExcludingValuationAllowancePercent
0.138
CY2022Q1 idcc Effective Income Tax Rate Reconciliation Excluding Valuation Allowance Percent
EffectiveIncomeTaxRateReconciliationExcludingValuationAllowancePercent
0.192
CY2023Q1 idcc Discrete Tax Expense Benefit
DiscreteTaxExpenseBenefit
-1000000 usd
CY2022Q1 idcc Discrete Tax Expense Benefit
DiscreteTaxExpenseBenefit
-300000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
105259000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
17994000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28780000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30703000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
592000 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
572000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29372000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31275000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.66
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2023Q1 idcc Dilutive Securities Effect On Basic Earnings Per Share Per Share
DilutiveSecuritiesEffectOnBasicEarningsPerSharePerShare
0.08
CY2022Q1 idcc Dilutive Securities Effect On Basic Earnings Per Share Per Share
DilutiveSecuritiesEffectOnBasicEarningsPerSharePerShare
0.01
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.58
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7908000 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5335000 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
430625000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
693479000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
783016000 usd
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
12085000 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
9682000 usd
CY2022Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
5716000 usd
CY2023Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
0 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
0 usd
CY2022Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1081000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
442710000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
703161000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
789813000 usd
CY2023Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
962769000 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1211459000 usd
CY2021Q4 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
30100000 usd
CY2022Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
5900000 shares
CY2022Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
106.37
CY2019Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
4900000 shares
CY2019Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
109.43
CY2023Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
109.43
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1700000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-300000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
95720000 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
11680000 usd
CY2022Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
209000 usd
CY2023Q1 idcc Other Income Expense
OtherIncomeExpense
1511000 usd
CY2022Q1 idcc Other Income Expense
OtherIncomeExpense
-1214000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13191000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1005000 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
11700000 usd
CY2023Q1 idcc Increase Decrease In Interest And Investment Income
IncreaseDecreaseInInterestAndInvestmentIncome
11500000 usd
CY2023Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
1000000 usd
CY2022Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
-800000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
700000 usd
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-400000 usd
CY2023Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
66854000 usd
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
64117000 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13447000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9044000 usd
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
12085000 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
9682000 usd
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Intangible Assets Current
DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent
1500000 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Intangible Assets Current
DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent
4000000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
7806000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2873000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
101692000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
89716000 usd
CY2023Q1 us-gaap Restructuring Reserve
RestructuringReserve
3100000 usd
CY2023Q1 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
31967000 usd
CY2022Q4 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
29370000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
22421000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
22421000 usd
CY2023Q1 us-gaap Other Long Term Investments
OtherLongTermInvestments
19715000 usd
CY2022Q4 us-gaap Other Long Term Investments
OtherLongTermInvestments
19593000 usd
CY2023Q1 us-gaap Deposit Contracts Assets
DepositContractsAssets
19573000 usd
CY2022Q4 us-gaap Deposit Contracts Assets
DepositContractsAssets
2544000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17431000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18034000 usd
CY2023Q1 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
3639000 usd
CY2022Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
3758000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
114746000 usd
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
4500000 usd
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
4495000 usd
CY2023Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
1487000 usd
CY2023Q1 us-gaap Restructuring Reserve Translation And Other Adjustment
RestructuringReserveTranslationAndOtherAdjustment
52000 usd
CY2023Q1 us-gaap Restructuring Reserve
RestructuringReserve
3060000 usd
CY2023Q1 us-gaap Severance Costs1
SeveranceCosts1
0 usd
CY2022Q1 us-gaap Severance Costs1
SeveranceCosts1
527000 usd
CY2023Q1 us-gaap Other Restructuring Costs
OtherRestructuringCosts
0 usd
CY2022Q1 us-gaap Other Restructuring Costs
OtherRestructuringCosts
15000 usd
CY2023Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
0 usd
CY2022Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
542000 usd

Files In Submission

Name View Source Status
0001405495-23-000020-index-headers.html Edgar Link pending
0001405495-23-000020-index.html Edgar Link pending
0001405495-23-000020.txt Edgar Link pending
0001405495-23-000020-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
idcc-20230331.htm Edgar Link pending
idcc-20230331.xsd Edgar Link pending
idcc-q133123ex311.htm Edgar Link pending
idcc-q133123ex321.htm Edgar Link pending
idcc-q133123ex322.htm Edgar Link pending
idccq133123ex312.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
idcc-20230331_cal.xml Edgar Link unprocessable
idcc-20230331_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
idcc-20230331_lab.xml Edgar Link unprocessable
idcc-20230331_pre.xml Edgar Link unprocessable
idcc-20230331_htm.xml Edgar Link completed
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending